FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225001078> ?p ?o ?g. }

• W4225001078 endingPage "416" @default.
• W4225001078 startingPage "406" @default.
• W4225001078 abstract "Background and aims. Patients with Myasthenia gravis (MG) are considered vulnerable as they may present with respiratory muscle weakness and because they are on immunosuppressive treatment; thereby, COVID-19 may have a detrimental effect on these patients. Vaccines against COVID-19 are currently available and it has been shown as they can prevent severe COVID-19 in vulnerable patients. Notwithstanding their efficacy, vaccine hesitancy has not been completely dispelled in the general population. Unfortunately, there is limited data about the safety of these vaccines in MG patients. The aims of this study are to evaluate the impact of COVID-19 in a MG cohort, the adherence to COVID-19 vaccination in Italy and vaccine safety in MG patients. Methods. A retrospective cohort study of MG patients attending the Neuromuscular Clinic of the University Hospital “Paolo Giaccone” of Palermo, Italy, was performed. Patients underwent telephone interviews with a dedicated questionnaire on SARS-CoV-2 vaccination and infection. Vaccine safety was assessed though the evaluation of vaccine-related adverse events (AEs) and comparisons of MG-ADL scores before and after vaccination. Patient worsening was defined as two or more point increases in MG-ADL scores. Results. From a total of 90 participants, 75 answered the questionnaire and 70.5% of them (n = 53) received the vaccine; ten patients did not receive vaccination and 3 patients were partially vaccinated. Among the vaccinated patients, about 45% (n = 24) experienced at least one AE, with a complete resolution within one week. No serious AEs and life-threatening conditions were observed. Globally, MG-ADL scores did not worsen after vaccination. Nine unvaccinated patients experienced SARS-CoV2 infection and four of them (44%) died—one patient required respiratory support, whereas three patients were asymptomatic. Conclusions. COVID-19 significantly impacted MG patients with an increase in mortality due to respiratory sequelae. Vaccines against SARS-CoV-2 showed good short-term safety in MG patients, who may take advantage of vaccination to avoiding life-threatening complications such as COVID-19 pneumonia." @default.
• W4225001078 created "2022-04-29" @default.
• W4225001078 creator A5001168773 @default.
• W4225001078 creator A5025525636 @default.
• W4225001078 creator A5026994664 @default.
• W4225001078 creator A5046765579 @default.
• W4225001078 creator A5063817823 @default.
• W4225001078 creator A5073054500 @default.
• W4225001078 creator A5079780570 @default.
• W4225001078 creator A5086467676 @default.
• W4225001078 date "2022-04-27" @default.
• W4225001078 modified "2023-09-30" @default.
• W4225001078 title "Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort" @default.
• W4225001078 cites W173166459 @default.
• W4225001078 cites W2025402613 @default.
• W4225001078 cites W2025558091 @default.
• W4225001078 cites W2101141037 @default.
• W4225001078 cites W2102703420 @default.
• W4225001078 cites W2135373024 @default.
• W4225001078 cites W2137544340 @default.
• W4225001078 cites W2139573761 @default.
• W4225001078 cites W2260688820 @default.
• W4225001078 cites W2330286114 @default.
• W4225001078 cites W2556737993 @default.
• W4225001078 cites W2745158458 @default.
• W4225001078 cites W2899835491 @default.
• W4225001078 cites W2913996891 @default.
• W4225001078 cites W2916599842 @default.
• W4225001078 cites W2945741166 @default.
• W4225001078 cites W2957961967 @default.
• W4225001078 cites W3016280125 @default.
• W4225001078 cites W3017302885 @default.
• W4225001078 cites W3023488256 @default.
• W4225001078 cites W3036555216 @default.
• W4225001078 cites W3042434795 @default.
• W4225001078 cites W3042833857 @default.
• W4225001078 cites W3044473288 @default.
• W4225001078 cites W3049263890 @default.
• W4225001078 cites W3084510004 @default.
• W4225001078 cites W3102128080 @default.
• W4225001078 cites W3111255098 @default.
• W4225001078 cites W3111590711 @default.
• W4225001078 cites W3119146398 @default.
• W4225001078 cites W3121660181 @default.
• W4225001078 cites W3123614326 @default.
• W4225001078 cites W3126874508 @default.
• W4225001078 cites W3130918599 @default.
• W4225001078 cites W3132728920 @default.
• W4225001078 cites W3133745688 @default.
• W4225001078 cites W3140500424 @default.
• W4225001078 cites W3141866361 @default.
• W4225001078 cites W3146861030 @default.
• W4225001078 cites W3157637563 @default.
• W4225001078 cites W3158791602 @default.
• W4225001078 cites W3164663652 @default.
• W4225001078 cites W3175897437 @default.
• W4225001078 cites W3193321644 @default.
• W4225001078 cites W4205483821 @default.
• W4225001078 cites W4225366643 @default.
• W4225001078 cites W4245522537 @default.
• W4225001078 cites W431098437 @default.
• W4225001078 doi "https://doi.org/10.3390/neurolint14020033" @default.
• W4225001078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35645352" @default.
• W4225001078 hasPublicationYear "2022" @default.
• W4225001078 type Work @default.
• W4225001078 citedByCount "26" @default.
• W4225001078 countsByYear W42250010782022 @default.
• W4225001078 countsByYear W42250010782023 @default.
• W4225001078 crossrefType "journal-article" @default.
• W4225001078 hasAuthorship W4225001078A5001168773 @default.
• W4225001078 hasAuthorship W4225001078A5025525636 @default.
• W4225001078 hasAuthorship W4225001078A5026994664 @default.
• W4225001078 hasAuthorship W4225001078A5046765579 @default.
• W4225001078 hasAuthorship W4225001078A5063817823 @default.
• W4225001078 hasAuthorship W4225001078A5073054500 @default.
• W4225001078 hasAuthorship W4225001078A5079780570 @default.
• W4225001078 hasAuthorship W4225001078A5086467676 @default.
• W4225001078 hasBestOaLocation W42250010781 @default.
• W4225001078 hasConcept C126322002 @default.
• W4225001078 hasConcept C167135981 @default.
• W4225001078 hasConcept C187212893 @default.
• W4225001078 hasConcept C197934379 @default.
• W4225001078 hasConcept C201903717 @default.
• W4225001078 hasConcept C203014093 @default.
• W4225001078 hasConcept C22070199 @default.
• W4225001078 hasConcept C2778105408 @default.
• W4225001078 hasConcept C2779134260 @default.
• W4225001078 hasConcept C2908647359 @default.
• W4225001078 hasConcept C3008058167 @default.
• W4225001078 hasConcept C524204448 @default.
• W4225001078 hasConcept C71924100 @default.
• W4225001078 hasConcept C72563966 @default.
• W4225001078 hasConcept C99454951 @default.
• W4225001078 hasConceptScore W4225001078C126322002 @default.
• W4225001078 hasConceptScore W4225001078C167135981 @default.
• W4225001078 hasConceptScore W4225001078C187212893 @default.
• W4225001078 hasConceptScore W4225001078C197934379 @default.
• W4225001078 hasConceptScore W4225001078C201903717 @default.

• next